Femasys (FEMY) Work In Process (2020 - 2026)
Femasys' (FEMY) quarterly Work In Process came in at $1.6 million in Q1 2026, up 48.75% YoY from $1.1 million in Q1 2025, and up 25.09% on a QoQ basis from $1.3 million in Q4 2025.
Femasys (FEMY) Work In Process (2020 - 2026) Analysis & Trends
Femasys (FEMY) has 7 years of Work In Process data on file, last reported at $1.6 million in Q1 2026.
- Quarterly Work In Process rose 48.75% year-over-year to $1.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.6 million (up 48.75% YoY) and the FY2025 annual result came in at $1.3 million, up 28.89% from the prior year.
- Work In Process grew to $1.6 million in Q1 2026, from $1.3 million in the prior quarter.
- In the past five years, Work In Process ranged from a high of $1.6 million in Q1 2026 to a low of $51358.0 in Q3 2023.
- A 5-year average of $550761.8 and a median of $131657.0 in 2024 frame the typical range for Work In Process.
- Annual changes were most pronounced in 2023 — Work In Process plunged 34.81% — and 2024, when it surged 891.5%.
- Tracing FEMY's Work In Process over 5 years: stood at $100453.0 in 2022, then increased by 28.41% to $128993.0 in 2023, then surged by 661.77% to $982630.0 in 2024, then advanced by 28.89% to $1.3 million in 2025, then increased by 25.09% to $1.6 million in 2026.
- The last three Work In Process figures came in at $1.6 million (Q1 2026), $1.3 million (Q4 2025), and $1.3 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 130.04 Bn | 124.82 Bn | 1.96 Bn |
| 2 | Becton Dickinson | 51.73 Bn | 50.87 Bn | 2.32 Bn |
| 3 | Alcon | 35.41 Bn | 34.06 Bn | 1.68 Bn |
| 4 | Resmed | 33.27 Bn | 31.80 Bn | 861.22 Mn |
| 5 | Medline | 28.23 Bn | 25.55 Bn | 2.22 Bn |
| 6 | West Pharmaceutical Services | 24.99 Bn | 24.55 Bn | 329.20 Mn |
| 7 | Solventum | 15.29 Bn | 14.88 Bn | 1.29 Bn |
| 8 | Cooper Companies | 14.79 Bn | 14.66 Bn | 735.40 Mn |
| 9 | Baxter International | 13.61 Bn | 11.46 Bn | 1.03 Bn |
| 10 | Femasys | 9.57 Mn | 8.12 Mn | 189,391.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.58 Mn |
| Dec 31, 2025 | 1.27 Mn |
| Sep 30, 2025 | 1.34 Mn |
| Jun 30, 2025 | 1.57 Mn |
| Mar 31, 2025 | 1.07 Mn |
| Dec 31, 2024 | 982,630.00 |
| Sep 30, 2024 | 509,217.00 |
| Jun 30, 2024 | 229,045.00 |
| Mar 31, 2024 | 131,657.00 |
| Dec 31, 2023 | 128,993.00 |
| Sep 30, 2023 | 51,358.00 |
| Jun 30, 2023 | 71,081.00 |
| Mar 31, 2023 | 98,775.00 |
| Dec 31, 2022 | 100,453.00 |
| Sep 30, 2022 | 78,777.00 |
| Jun 30, 2022 | 98,403.00 |
| Mar 31, 2022 | 55,709.00 |
| Dec 31, 2021 | 12,795.00 |
| Sep 30, 2021 | 39,879.00 |
| Jun 30, 2021 | 26,348.00 |